# CorMedix (CRMD) — Earnings

CRMD · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/crmd/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | $0.29 |
| EPS estimate | $0.24 |
| EPS surprise | +21.85% |
| Revenue surprise | +6.13% |
| Revenue | $101.9M |
| Revenue estimate | $96.0M |
| Reported | Aug 13, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1410098/000141009826000056/crmd-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/e5d50f19-ff69-8e5c-b3ee-2d7168d7596d.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 13, 2026 | $0.24 | $0.29 | 21.85% | $96.0M | $101.9M |
| Q1 2026 | May 14, 2026 | $0.34 | $0.43 | 25.40% | $105.0M | $127.4M |
| Q4 2025 | Mar 5, 2026 | $0.82 | $0.16 | -80.40% | $127.0M | $128.6M |
| Q3 2025 | Nov 12, 2025 | $0.63 | $1.26 | 98.64% | $86.0M | $104.3M |
| Q2 2025 | Aug 7, 2025 | $0.19 | $0.29 | 55.00% | $35.1M | $39.7M |
| Q1 2025 | May 6, 2025 | $0.26 | $0.30 | 15.38% | $36.9M | $39.1M |
| Q4 2024 | Mar 25, 2025 | $0.13 | $0.22 | 67.05% | $27.3M | $31.2M |
| Q3 2024 | Oct 30, 2024 | −$0.12 | −$0.05 | 59.02% | $10.3M | $11.5M |
| Q2 2024 | Aug 14, 2024 | −$0.25 | −$0.25 | 0.40% | $1.7M | $806,119.00 |
| Q1 2024 | May 9, 2024 | −$0.28 | −$0.25 | 9.71% | — | — |
| Q4 2023 | Mar 12, 2024 | −$0.20 | −$0.26 | -29.29% | — | — |
| Q3 2023 | Nov 14, 2023 | −$0.21 | −$0.17 | 19.05% | — | — |
| Q2 2023 | Aug 8, 2023 | −$0.24 | −$0.25 | -4.52% | — | — |
| Q1 2023 | May 15, 2023 | −$0.20 | −$0.24 | -19.46% | — | — |
| Q4 2022 | Mar 30, 2023 | −$0.19 | −$0.20 | -7.01% | $2,333.00 | $29,702.00 |
| Q3 2022 | Nov 10, 2022 | −$0.23 | −$0.17 | 26.09% | — | $6,817.00 |
| Q2 2022 | Aug 11, 2022 | −$0.21 | −$0.19 | 8.08% | — | $21,253.00 |
| Q1 2022 | May 12, 2022 | −$0.22 | −$0.18 | 18.18% | $25,000.00 | $7,636.00 |
| Q4 2021 | Mar 29, 2022 | −$0.23 | −$0.20 | 14.27% | $19,000.00 | $56,397.00 |
| Q3 2021 | Nov 9, 2021 | −$0.18 | −$0.22 | -24.50% | $20,000.00 | $38,088.00 |

## Frequently Asked Questions

### When did CorMedix (CRMD) last report earnings?

CorMedix last reported on Aug 13, 2026, covering fiscal Q2 2026.

### Did CRMD beat earnings estimates?

Yes. CorMedix reported EPS of $0.29 for Q2 2026 against a $0.24 estimate — a 21.85% beat.

### How much revenue did CRMD report last quarter?

CorMedix reported $101.9M in revenue for Q2 2026, against a consensus estimate of $96.0M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).